Table 3. Comparative analysis of synovial fluid and serum cartilage oligomeric matrix protein levels by sex.
SF COMP (n=151) | Serum COMP (n=152) | |||||
Median | Min-Max | p | Median | Min-Max | p | |
Total levels of COMP (ng/mL) | 676,6 | 25-2480 | 0.033*† | 257,5 | 18-2542 | 0.035*† |
KOA | 777 | 50-2480 | 314 | 18-2542 | ||
Control group | 676,3 | 25-836 | 228 | 57-810 | ||
Female KOA (ng/mL) | 891,2 | 50-2420 | 0.007*† | 296 | 18-2230 | 0.116† |
Female healthy individuals | 676,3 | 25-817,5 | 201 | 61-801 | ||
Male KOA (ng/mL) | 529 | 58-2480 | 0.875† | 343 | 32-2542 | 0.146† |
Male healthy individuals | 676,3 | 173-836 | 257,5 | 57-810 | ||
SF: Synovial fluid; COMP: Cartilage oligomeric matrix protein; Min: Minimum; Max: Maximum; KOA: Knee osteoarthritis; † Mann Whitney U test; * Significant if p<0.05; ** Significant if p<0.01. |